Related Experiment Video
Updated: May 1, 2026

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
Published on: February 28, 2017
Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine.
Anna Bajek1, Joanna Olkowska, Natalia Gurtowska
1Nicolaus Copernicus University, Department of Tissue Engineering , Karlowicza 24, 85-092 Bydgoszcz , Poland +48 525853737 ; +48 525853742 ; a_bajek@wp.pl.
Amniotic fluid-derived stem cells (AFSCs) offer potential for treating incurable diseases. Further analysis is needed to address limitations before clinical application of these promising stem cells.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Tissue engineering
Background:
- Early tissue engineering relied on adult cells, posing risks like invasiveness and disease transmission.
- The field has evolved, expanding the variety of available cell populations for therapeutic use.
Purpose of the Study:
- To comprehensively review amniotic fluid-derived stem cells (AFSCs).
- To explore the potential clinical applications of AFSCs.
Main Methods:
- Literature review of AFSCs.
- Analysis of characteristic features and potential applications.
Main Results:
- AFSCs possess unique characteristics suitable for regenerative medicine.
- Potential applications span various therapeutic areas, offering new treatment avenues.
Conclusions:
- AFSCs show significant promise for treating currently incurable diseases.
- Careful consideration of limitations and ethical questions is crucial before clinical translation of AFSC therapies.
Related Concept Videos
Stem Cell Culture
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Adult Stem Cells
Mesenchymal Stem Cells

